In order to identify the molecular determinants of human diseases, such as cancer, that 33 arise from a diverse range of tissue, it is necessary to accurately distinguish normal and 34 pathogenic cellular programs. 1-3 Here we present a novel approach for single-cell multi-35 omic deconvolution of healthy and pathological molecular signatures within phenotypically 36 heterogeneous malignant cells. By first creating immunophenotypic, transcriptomic and 37 epigenetic single-cell maps of hematopoietic development from healthy peripheral blood 38 and bone marrow mononuclear cells, we identify cancer-specific transcriptional and 39 chromatin signatures from single cells in a cohort of mixed phenotype acute leukemia 40 (MPAL) clinical samples. MPALs are a high-risk subtype of acute leukemia characterized 41 by a heterogeneous malignant cell population expressing both myeloid and lymphoid 42 lineage-specific markers. 4,5 Our results reveal widespread heterogeneity in the 43 pathogenetic gene regulatory and expression programs across patients, yet relatively 44 consistent changes within patients even across malignant cells occupying diverse portions 45 of the hematopoietic lineage. An integrative analysis of transcriptomic and epigenetic 46 maps identifies 91,601 putative gene-regulatory interactions and classifies a number of 47 transcription factors that regulate leukemia specific genes, including RUNX1-linked 48 regulatory elements proximal to CD69. This work provides a template for integrative, multi-49 omic analysis for the interpretation of pathogenic molecular signatures in the context of 50 developmental origin. 51 52 53 54 55 56 57 3 Main 58 To identify pathologic features within neoplastic cells, we first aimed to establish molecular 59 features of normal development for comparison. Since MPALs present with features of 60 multiple hematopoietic lineages, we first constructed independent immunophenotypic, 61 transcriptomic and epigenetic maps of normal blood development using droplet-based 62 CITE-seq 6 (single-cell antibody derived tag and RNA sequencing) and single-cell ATAC-63 seq (scATAC-seq, single-cell chromatin accessibility profiling) 7 on bone marrow and 64 peripheral blood mononuclear cells (Figure 1a) . For CITE-seq analyses, we 65 simultaneously generated 10x Genomics 3 ' single-cell RNA sequencing 8 (scRNA-seq) and 66 antibody derived tag sequencing 6 (scADT-seq) libraries from 35,882 bone marrow 67 mononuclear cells (BMMCs, n = 12,602), CD34 + enriched BMMCs (n = 8,176), and 68 peripheral blood mononuclear cells (PBMC, n = 14,804). On average, 1,273 informative 69 genes (2,370 unique transcript molecules) were detected per cell and replicates were 70 highly correlated ( Supplementary Figure 1a -b). We then selected a feature set of 71 transcripts to mitigate batch effects and linearly projected retained transcript counts into a 72 lower dimensional space using Latent Semantic Indexing (LSI, see Online Methods). 9,10 73 Cells were clustered using Seurat's Shared Nearest Neighbor approach 11 , annotated 74 using a manually curated maker gene list, and visualized using uniform manifold 75 approximation and projection (UMAP) 12 (Figure 1b, Supplementary Figure 1c -d).
6 cells to the projected cells we can identify the hematopoietic developmental compartment.
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This method does not require defining discrete cell type boundaries and uses a large 137 feature set to robustly position cells within the continuous landscape of hematopoiesis. To 138 validate this approach, we first projected downsampled, published bulk RNA-seq and 139 ATAC-seq data 18 from FACS-sorted subpopulations into our chromatin and transcription 140 hematopoietic maps and found high concordance with our healthy hematopoietic map and 141 cluster definitions ( Supplementary Figure 8b) . To further validate our approach, we 142 projected published scRNA-seq 19 and scATAC-seq 20-22 data from different platforms and 143 different genomes on our chromatin and transcription hematopoietic maps and found 144 striking agreement ( Supplementary Figure 8c) . These results confirm that this method can 145 accurately identify the hematopoietic signature for chromatin and gene expression at 146 single-cell resolution.
147
Using this LSI projection framework and landscapes of healthy hematopoiesis, we 148 next sought to deconvolve the normal and leukemic signatures of MPAL samples at single-149 cell resolution. First, the leukemic single cells are projected into the hematopoietic linear 150 LSI subspace. Next we identify a non-redundant set of healthy hematopoietic cells that 151 were nearest neighbor normal cells to each leukemic cell, irrespective of their cell-type 152 boundaries. Lastly, we compute the differences between the leukemic cells and nearest 153 normal cells to identify the leukemic specific signature. We first tested our approach by 154 analyzing recently published scRNA-seq data from acute myeloid leukemia (AML) patient 155 samples 19 . By projecting the AMLs into our healthy hematopoietic map, we see general and across different cytogenetic subtypes. In addition, we found that the MPALs assayed 197 in this study were representative of previous characterized MPALs 16 (Figure 2e) . Given 198 that we were insufficiently powered to detect unique leukemic differences between AML 199 and our MPAL samples when analyzing downsampled bulk data, we compared the 
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Having compared our leukemic transcriptomic programs to other studies we 209 wanted to identify the key TFs that regulate these programs. First, we identified which TF 210 were differentially enriched in each k-means cluster of differentially accessible peaks 211 observed in Figure 2c . (Figure 3a) . We found that RUNX1 motifs were highly enriched in 9 both cluster 4 and 10 -the two clusters corresponding to the most commonly shared accessible elements across MPAL subset populations. In addition, RUNX1 is significantly suppressor with loss-of-function mutations in AML 27 , myelodysplastic syndrome (MDS) 28 , 217 and ETP T-ALL 29,30 , and as a putative oncogene in non-ETP T-ALL 31,32 . Furthermore,
218
wildtype RUNX1 has been implicated as a potential driver of leukemogenesis in core-219 binding factor (CBF) leukemia 33 and mixed lineage leukemia 34 .
220
To link RUNX1 and other putative regulatory TFs to their leukemic programs we 221 first developed an analytical framework that utilizes both our transcriptomic and chromatin 222 single-cell data to link putative regulator peaks to target genes. Using our matched 
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We next identified 91,601 peak-to-gene links by correlating accessibility changes of ATAC 232 peaks within 250 kb of the gene promoter with the expression of the gene independently 233 for both healthy and MPAL aggregates (Figure 3b ). This analysis revealed peak-to-gene 234 links that were specific to healthy hematopoiesis, others that were specific to MPALs, and 235 a conserved subset that was shared across both hematopoiesis and MPALs. We 10 for peaks mapped per gene, genes mapped per peak, number of skipped genes and the 239 peak-to-gene as previously observed in a similar linkage analyses 2 (Supplementary Figure   240 14e). To further support these peak-to-gene links, we used previously published K27ac
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HiChIP in primary T cells and a Human Coronary Artery Smooth Muscle Cells (HCASMC) 242 cell-line and found that the T/NK biased peak-to-gene links were more enriched in the T 243 cells than the HCASMC cell line 36 ( Supplementary Figure 14f ). We next examined GTEx 244 eQTL mappings within our inferred peak-to-gene links, finding enrichment of eQTLs in 245 several functionally related categories such as Whole Blood and Lymphocytes
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( Supplementary Figure 14g ). To demonstrate the utility of these peak-to-gene links, we 247 linked differentially accessible regions to known leukemic genes such as the surface 248 protein CD96, the leukemic stem cell marker IL1RAP, the cytokine receptor FLT3, and 249 apoptosis regulator MCL1 ( Supplementary Figure 15a-d) . Overall, these analyses, 250 support that our peak-to-gene links are highly enriched in immune regulation and across 251 other previously published linkage data sets 2,36 .
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Having established a high-quality set of peak-to-gene links, we aimed to identify 253 the set of malignant genes putatively regulated by RUNX1. First, we utilized our peak-to-254 gene links to identify differential peaks linked to a differential gene within at least 2 MPAL 255 subpopulations. Next, we selected all linked differential accessibility sites that contain the 256 RUNX1 motif. Finally, for each linked gene we combined all linked peaks to create a 257 differential linkage score (see methods) and compared this score to the proportion of 258 MPAL subpopulations that exhibited differential expression and accessibility in at least 259 one linked peak and target gene (a measure of how common this RUNX1-driven 260 dysfunction is across MPAL subsets) (Figure 3c ). Using this approach, we found 732 261 genes putatively regulated by a RUNX1-containing distal element in at least 2 MPAL 262 subsets, and found that CD69, gene implicated in lymphocyte activation through initiation 263 of JAK/STAT signaling 37 and lymphocyte retention in lymphoid organs 38 , was both highly 264 11 enriched in the calculated differential linkage score and was observed to be differentially screens 40 , and RUNX1 ChIP-seq 41 onto our multi-omic differential track. These orthogonal 268 data sets show RUNX1 binding to linked distal regulatory regions (Figure 3e ). Finally, by 269 using the 732 identified RUNX1 target genes to stratify TCGA AML 42 patients by 270 expression, we observe significantly decreased survival (p-value = 0.023) in donors with 271 a high RUNX1 target gene signature 42 (Figure 3f ). This analysis suggests that RUNX1 is with a previous report 16 that MPAL cells likely originate from a multipotent progenitor cell, 279 thereby sharing a common mutational landscape while populating different regions of the 280 hematopoietic tree. We used integrative single-cell analyses to further define putative TF 281 regulation of these malignant programs. We inferred that RUNX1 acts as a potential 282 oncogene in MPAL, regulating malignant genes associated with poor survival. We 283 anticipate that similar approaches will be used in future studies to both identify the 284 differentiation status of different tumor types (i.e. identify the closest "normal" cell type) as 
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(10 cycles) with custom barcodes (see Supplementary Table 3) Table 2 ). Lymphocytes were identified by low side-scatter and bright CD45 expression.
347
The gate was validated by backgating on CD3-positive or CD19-positive events. Blasts 
369
To ensure that each single-cell was both adequately sequenced and had high signal to 370 background, we filtered cells with less than 1000 unique fragments and enrichment at 371 transcription start sites (TSS) was below 8. To calculate a TSS enrichment 2 , briefly Tn5 372 corrected insertions were aggregated +/-2,000 bp relative (TSS strand-corrected) for each 373 unique TSS genome wide. This profile was normalized to the mean accessibility +/-1,900-374 2,000 bp from the TSS, smoothed every 51bp, and the maximum smoothed value was 375 reported as TSS enrichment in R. We estimate that the multiplet percentage for this study 376 was around 4% 7 .
378 scATAC-seq Counts Matrix

379
To construct a counts matrix for each cell by each feature (window or peaks), we read 380 each fragment.tsv.gz fill into a Genomic Ranges object. For each Tn5 insertion, the "start" 
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We adapted a previous workflow for generating a union peak set that will account for 389 diverse subpopulation structure 2,9,10 . First, we created 2.5kb windows genome wide using 390 "tile(hg19chromSizes, width = 2500)" in R. Next, a cell by 2.5kb window sparse matrix was 391 constructed as described above. The top 20,000 accessible windows were kept and the 392 binarized matrix was transformed with the term frequency-inverse document frequency compute the cell "term frequency". Next we multiplied these values by log(1 + ncol(matrix) 395 / rowSums(matrix)) which represents the "inverse document frequency". This 396 normalization resulted in a TF-IDF matrix that was then used as input to irlba's singular 
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Overlapping peaks called were handled using an iterative removal procedure as 411 previously described 2 . First, the most significant (MACS2 score) extended peak summit is 412 kept and any peak that directly overlaps with that significant peak is removed. This process 413 re-iterates to the next most significant peak until all peaks have either been kept or 414 removed due to direct overlap with a more significant peak. The most significant 200,000 415 extend peak summits for each cluster were quantile normalized using 416 "trunc(rank(v))/length(v)" in R (where v represents the vector of MACS2 peaks scores).
417
These cluster peak sets were then merged and the previous iterative removal procedure 418 was used. Lastly, we removed any peaks whose nucleotide content had any "N" and MPALs). We found that in some cases, that there was batch effect between 432 experiments. To minimize this effect, we identified the top 50,000 variable peaks across 433 the initial clusters (summed cell matrix for each cluster followed by edgeR logCPM 434 transformation 44 ). These 50,000 variable peaks were then used to subset the sparse 435 binarized accessibility matrix and recomputed the "TF-IDF" transform. We used singular 436 value decomposition on the TF-IDF matrix to generate a lower dimensional representation 437 of the data by retaining the first 50 dimensions. We then used these reduced dimensions 
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To visualize scATAC-seq data, we read the fragments into a GenomicRanges object in R.
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We then computed sliding windows across each region we wanted to visualize every 100 451 bp "slidingWindows(region,100,100)". We computed a counts matrix for Tn5-corrected 452 insertions as described above and then binarized this matrix. We then returned all non- We measured global TF activity using chromVAR 15 . We used the cell by peaks and the 461 CIS-BP motif (from chromVAR motifs "human_pwms_v1") matches within these peaks 462 from motifmatchr. We then computed the GC bias-corrected deviations using the We kept genes that were present in both 10x gene transfer format (GTF) files v3.0.0 for 
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We wanted to filter out cells whose transcripts were lowly captured and first plotted the 499 distribution of genes detected and UMIs for all experiments. Based on these plots we 500 chose to filter out cells that had less than 400 informative genes detected and 1000 UMIs.
501
In addition, to lower multiplet representation, we filtered cells with above 10,000 UMIs. We 502 estimate that the multiplet percentage for this study was around 6% 8 . We then plotted the 503 correlation for each replicate experiment and found high reproducibility.
504 505
scRNA-seq-centric Latent Semantic Indexing clustering and visualization
506
We initially tested out a few methods for clustering scRNA but settled on an approach that 507 enabled us to effectively capture the hematopoietic hierarchy without significant alteration 508 of transcripts expression. We first log-normalized the transcript counts by first depth 509 normalizing to 10,000 and adding a pseudo count prior to a log2 transform (log2(counts 510 per ten thousand transcripts + 1)). Next, we identified the top 3000 variable genes and 511 performed the TF-IDF transform on these 3000 genes. We then performed singular value Seurat SNN resolution of 0.8 and 0.8). We then determined which clusters were "healthy-559 like" if a high percentage (>80% for scRNA, >90% for scATAC) of the cells were from the 560 hematopoietic data. MPAL single cells belonging to these clusters were classified as 561 "healthy-like" and the remaining disease-like. We note that we did not detect significant 562 large-scale copy number amplifications with our previously described approach 7 , and the 563 proportion of "disease-like" classified cells were consistent with our FACS estimation of 564 percent blast cells. In order to accurately characterize these MPAL "disease-like" by their 565 hematopoietic state, we established "hematopoietic compartments" across our scRNA 566 and scATAC-seq maps that broadly characterized the hematopoietic continuum. The
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borders for these compartments were determined empirically using "fhs" in R, guided by 568 the initial clusters and agreement across the scRNA and scATAC-seq classifications. After 569 the hematopoietic continuum were classified, we then broadly classified the MPAL 570 "disease-like" cells based on their projected nearest neighbor in the UMAP subspace.
571
These classifications were used subsequently in differential analyses.
573
Identifying differential features with scATAC and scRNA-seq 23
To identify differential features for previously published AML data and MPALs, we 575 constructed a nearest neighbor healthy aggregate using the following approach. First, we in LSI-SVD space. For each projected population, we used a minimum of 50 and maximum 579 of 500 cells (random sampling) as input. Next, we took the unique of all hematopoietic 580 single-cells and if this number was greater than 1.25 times the number of the projected 581 populations, we took the nearest 24 cells and repeated this procedure until this criterion 582 was met. Then the projected population and non-redundant hematopoietic cells were 583 downsampled to an equal number of cells (maximum 500). For scATAC-seq, we binarized 584 the matrix for both the projected populations and hematopoietic matrices. Next, we scaled 585 the sparse matrices to 10,000 total counts for scRNA and 5,000 total promoter counts for 586 scATAC-seq (promoter peaks defined as peaks within 500 bp of TSS from hg19 10x v3.0.0 587 gtf file). Next, we computed row-wise t-tests for each feature. We then calculated the FDR 588 using p.adjust(method="fdr"). We then computed the log2 mean and log2 fold changes for 589 each feature. We chose these parameters based on Soneson et al., study comparing 590 analytical methods for differential expression 45 . For scRNA-seq, differential expression 591 was determined by FDR < 0.01 and absolute log2 fold changes greater than 0.5. For 592 scRNA-seq, differential expression was determined by FDR < 0.05 and absolute log2 fold 593 changes greater than 0.05.
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To identify differential genes for bulk leukemia RNA-seq, we downsampled the gene 596 counts to 10,000 counts randomly for 250 times. We then projected and used the above 597 framework to resolve differential genes with log2 fold change > 3 and FDR < 0.01. We 598 then removed genes that were differential in 33% or higher of the normal samples to or higher of the leukemia samples. This filtering biases our identified malignant genes to 601 those variable across the leukemic types vs conserved across all leukemic types. We then 602 took the average malignancy for each remaining gene for each leukemic type and used 603 the top 300 variable malignant genes across the leukemic types for heatmap and LSI. For 604 computing differential LSI, we binarized each gene being malignant or not for the 300 605 variable malignant genes and computed the TF-IDF transform followed by SVD (LSI). We 606 then visualized this in 2 dimensions using uwot's implementation of UMAP (50 SVD 607 dimensions, n_neighbors = 50, min_dist = 0.005).
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Matching scATAC-scRNA-seq pairs using Seurat Canonical Correlation Analyses
610
We wanted to be able to integrate our epigenetic and transcriptomic data and built off of 611 previous approaches for integration 10, 35 . We found the approach that worked best for our 
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and scRNA. We then filtered cells where the variance explained by CCA is less than 2 fold 625 compared to PCA. We then Aligned the subspaces with "AlignSubspace" and 25 25 dimensions to align with reduction.type = "cca" and grouping.var = "protocol". We then
Identifying TF Malignant Target Genes and Survival Anlaysis
We wanted to create a framework for identifying TFs that potentially directly regulate 704 malignant genes. To do this analysis, we first identified a set of transcription factors whose 705 hypergeometric enrichment in differential peaks were high across the MPAL 706 subpopulations (Comparing up-regulated peaks vs all peaks) and were identified as being 707 transcriptionally correlated with their motif's accessibility (see above). Next for a given TF 708 and all identified peak-to-gene links, we further subsetted these links by those containing 709 the TF motif. Then for each MPAL subpopulation, we determined for each peak-to-gene 710 link if both the peak and gene are up-regulated. Then for each gene, we gave a binary 711 score whether or not that MPAL subpopulation has at least one differential peak-to-gene 712 link (whose peak and gene are differentially up-regulated) and report the proportion of 713 subpopulations that were up-regulated. In addition, for each gene that has at least 1 714 differential peak-to-gene links we summed their squared correlation R 2 and report that as 715 the differential linkage score. We kept all genes that had least 1 MPAL subpopulation with 716 corresponding differential peak-to-gene links.
718
For survival analysis, we downloaded the RPKM TCGA-LAML data 42 (https://tcga-719 data.nci.nih.gov/docs/publications/laml_2012/laml.rnaseq.179_v1.0_gaf2.0_rpkm_matrix
720
.txt.tcgaID.txt.gz). We downloaded the survival data from Bioconductor RTCGA.clinical 721 ("patient.vital_status") and matched using TCGA IDs the RPKM expression. Next, we took 722 all genes that were identified as target genes for RUNX1 (n = 732), and computed row-723 wise z-scores for each gene. Next, we took the column means of this matrix to get an 724 average z-score across all RUNX1 target genes. We then identified the top 33% and 725 bottom 33% of donors based on this expression. We computed the p-value using the R 
